Trial record 1 of 1 for: CALGB 20202
Previous Study | Return to List | Next Study
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
This study has been withdrawn prior to enrollment.
Cancer and Leukemia Group B
Information provided by:
Alliance for Clinical Trials in Oncology
First received: May 9, 2009
Last updated: July 15, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||December 2018 (Final data collection date for primary outcome measure)|
Becker H, Marcucci G, Maharry K, Radmacher MD, Mrózek K, Margeson D, Whitman SP, Paschka P, Holland KB, Schwind S, Wu YZ, Powell BL, Carter TH, Kolitz JE, Wetzler M, Carroll AJ, Baer MR, Moore JO, Caligiuri MA, Larson RA, Bloomfield CD. Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood. 2010 Aug 5;116(5):788-92. doi: 10.1182/blood-2010-01-262543. Epub 2010 May 4.